jd health international inc. - JDHIF

JDHIF

Close Chg Chg %
7.07 0.51 7.21%

Open Market

7.58

+0.51 (7.21%)

Volume: 1.75K

Last Updated:

Dec 22, 2025, 1:45 PM EDT

Company Overview: jd health international inc. - JDHIF

JDHIF Key Data

Open

$7.58

Day Range

7.58 - 7.58

52 Week Range

3.23 - 8.75

Market Cap

$24.10B

Shares Outstanding

3.21B

Public Float

1.03B

Beta

0.33

Rev. Per Employee

N/A

P/E Ratio

36.37

EPS

N/A

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

N/A

 

JDHIF Performance

1 Week
 
7.21%
 
1 Month
 
-5.60%
 
3 Months
 
134.67%
 
1 Year
 
8.29%
 
5 Years
 
N/A
 

JDHIF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About jd health international inc. - JDHIF

JD Health International, Inc. operates as an online healthcare platform and retail pharmacy company. Its technology-driven platform is cantered on the supply chain of pharmaceutical and healthcare products and healthcare services, encompassing a user’s full life span for all healthcare needs. The firm's retail pharmacy business operates through three models: direct sales, online marketplace and Omni channel initiative. It offers comprehensive online healthcare services, such as online consultation and prescription renewal, chronic disease management, family doctor and consumer healthcare. Its platform allows doctors to practice multisite, acquire and manage targeted patients, conduct healthcare research, exchange academic and clinical knowledge and improve diagnostic and treatment skills. The company was founded on November 30, 2018 and is headquartered in Beijing, China.

JDHIF At a Glance

JD Health International, Inc.
8th Floor, Building C
Beijing, Beijing 101111
Phone N/A Revenue 8.08B
Industry Medical Distributors Net Income 578.29M
Sector Distribution Services 2024 Sales Growth 6.962%
Fiscal Year-end 12 / 2025 Employees 3,564
View SEC Filings

JDHIF Valuation

P/E Current 36.565
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 19.66
Price to Sales Ratio 1.415
Price to Book Ratio 1.529
Price to Cash Flow Ratio 19.03
Enterprise Value to EBITDA 23.221
Enterprise Value to Sales 0.55
Total Debt to Enterprise Value 0.008

JDHIF Efficiency

Revenue/Employee 2,267,489.685
Income Per Employee 162,258.557
Receivables Turnover 70.403
Total Asset Turnover 0.858

JDHIF Liquidity

Current Ratio 3.767
Quick Ratio 3.362
Cash Ratio 3.303

JDHIF Profitability

Gross Margin 22.883
Operating Margin 2.00
Pretax Margin 8.394
Net Margin 7.156
Return on Assets 6.142
Return on Equity 7.962
Return on Total Capital 7.607
Return on Invested Capital 7.942

JDHIF Capital Structure

Total Debt to Total Equity 0.468
Total Debt to Total Capital 0.466
Total Debt to Total Assets 0.363
Long-Term Debt to Equity 0.269
Long-Term Debt to Total Capital 0.268
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Jd Health International Inc. - JDHIF

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
4.76B 6.94B 7.56B 8.08B
Sales Growth
+69.41% +45.89% +8.86% +6.96%
Cost of Goods Sold (COGS) incl D&A
3.64B 5.47B 5.88B 6.23B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
9.79M 20.89M 32.10M 29.83M
Depreciation
- - - -
-
Amortization of Intangibles
- - - -
-
COGS Growth
+73.75% +50.26% +7.47% +5.98%
Gross Income
1.12B 1.47B 1.67B 1.85B
Gross Income Growth
+56.64% +31.63% +14.01% +10.42%
Gross Profit Margin
+23.46% +21.16% +22.17% +22.88%
2021 2022 2023 2024 5-year trend
SG&A Expense
1.33B 1.49B 1.59B 1.69B
Research & Development
138.45M 158.48M 173.11M 184.86M
Other SG&A
1.20B 1.33B 1.41B 1.50B
SGA Growth
+101.62% +11.76% +6.38% +6.43%
Other Operating Expense
- - - -
-
Unusual Expense
- - - -
-
EBIT after Unusual Expense
(217.70M) (21.55M) 89.04M 161.59M
Non Operating Income/Expense
93.45M 140.60M 302.43M 517.94M
Non-Operating Interest Income
70.95M 128.35M 275.09M 272.41M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
930.17K 1.35M 1.34M 1.14M
Interest Expense Growth
+87.95% +45.27% -0.93% -14.95%
Gross Interest Expense
930.17K 1.35M 1.34M 1.14M
Interest Capitalized
- - - -
-
Pretax Income
(125.18M) 117.70M 390.13M 678.38M
Pretax Income Growth
+94.92% +194.03% +231.46% +73.89%
Pretax Margin
-2.63% +1.70% +5.16% +8.39%
Income Tax
26.56M 46.42M 77.69M 88.88M
Income Tax - Current - Domestic
35.19M 61.54M 64.12M 70.07M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(8.63M) (15.12M) 13.58M 18.81M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(166.34M) 56.91M 302.45M 577.62M
Minority Interest Expense
106.83K 463.93K 146.65K (671.13K)
Net Income
(166.45M) 56.45M 302.31M 578.29M
Net Income Growth
+93.33% +133.91% +435.55% +91.29%
Net Margin Growth
-3.50% +0.81% +4.00% +7.16%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(166.45M) 56.45M 302.31M 578.29M
Preferred Dividends
- - - -
-
Net Income Available to Common
(166.45M) 56.45M 302.31M 578.29M
EPS (Basic)
-0.0538 0.0182 0.0968 0.184
EPS (Basic) Growth
+93.14% +133.83% +431.87% +90.08%
Basic Shares Outstanding
3.09B 3.11B 3.12B 3.14B
EPS (Diluted)
-0.0538 0.018 0.0955 0.183
EPS (Diluted) Growth
+93.14% +133.46% +430.56% +91.62%
Diluted Shares Outstanding
3.09B 3.14B 3.16B 3.16B
EBITDA
(207.91M) (659.97K) 121.14M 191.42M
EBITDA Growth
-478.82% +99.68% +18,455.93% +58.01%
EBITDA Margin
-4.37% -0.01% +1.60% +2.37%

Jd Health International Inc. in the News